Today: 30 April 2026
Browse Category

Stock Market 30 January 2026

ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX

ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX

ImmunityBio shares climbed 5.9% to $6.26 Friday, rebounding from early losses despite declines in major biotech ETFs. The move followed a STAT News report that Chairman Patrick Soon-Shiong misrepresented an FDA meeting on Anktiva’s label expansion. Investors also tracked dilution risk after ImmunityBio amended a $505 million convertible note to allow partial conversions into stock.
30 January 2026
·
Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products and Chemicals shares rose 6.2% to $271.89 after fiscal Q1 adjusted EPS reached $3.16, beating estimates and topping guidance. Revenue climbed 6% to $3.1 billion. The company held its FY2026 adjusted EPS forecast at $12.85–$13.15 and expects capex near $4 billion. Helium weakness continued to weigh on volumes and pricing, especially in Asia.
30 January 2026
··
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog shares jumped 6.4% to $306.57 after the company posted record quarterly sales of $1.1 billion and raised its 2026 outlook. Bookings reached $2.3 billion, pushing backlog up 30% to $3.3 billion. The company lifted its quarterly dividend 3% to $0.30 per share. Free cash flow turned negative as Moog increased inventory and faced tariff pressures on margins.
30 January 2026
··
AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile shares fell 8.7% to $111.50 Friday, swinging from a session high of $129.74 to a low of $109.04 on heavy volume. Vanguard disclosed a 7.68% stake in the company as of Dec. 31 in a regulatory filing. Investors are watching for the planned late-February BlueBird 7 satellite launch aboard Blue Origin’s New Glenn-3 rocket.
30 January 2026
···
Abbott stock rebounds as Exact Sciences vote nears after broker upgrade

Abbott stock rebounds as Exact Sciences vote nears after broker upgrade

Abbott Laboratories shares rose 2.6% to $108.89 Friday after missing revenue targets and guiding first-quarter adjusted EPS below analyst estimates. Freedom Capital Markets upgraded the stock to “buy” but cut its price target. Abbott expects to close its $23 billion Exact Sciences acquisition by Q2 2026. Exact Sciences shareholders will vote on the merger Feb. 20.
30 January 2026
···
Citigroup stock edges up as Trump taps Warsh for Fed, inflation data tests rate bets

Citigroup stock edges up as Trump taps Warsh for Fed, inflation data tests rate bets

Citigroup shares rose 0.4% to $115.65 Friday, outperforming a broader U.S. stock decline as investors eyed a midnight federal funding deadline and awaited next week’s jobs report. The move followed Donald Trump’s nomination of Kevin Warsh for Fed chair and a surprise jump in producer prices. Most major bank stocks were little changed. The Fed left rates steady this week at 3.50%-3.75%.
30 January 2026
···
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
30 January 2026
····
TTM Technologies stock price rises as $200 million Raytheon contract keeps buyers interested

TTM Technologies stock price rises as $200 million Raytheon contract keeps buyers interested

TTM Technologies shares rose 2.6% to $98.98 Friday after landing a supply contract with Raytheon worth up to $200 million over three years. The deal covers hardware for Raytheon’s air and missile defense radar program. TTM will join the S&P MidCap 400, replacing Civitas Resources, which could spur index-driven buying. Jabil and Sanmina shares fell, while Plexus edged higher.
30 January 2026
·········
SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi Technologies shares fell 8% to $22.48 Friday after volatile trading, as investors reacted to strong Q4 profits and raised 2026 forecasts. The company reported record loan originations of $10.5 billion and a 78% jump in financial services income. SoFi now expects 2026 adjusted net revenue of $4.655 billion and adjusted EBITDA near $1.6 billion. Next earnings report is set for April 28.
30 January 2026
···
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
···
Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria shares rose 3.1% to $61.61 Friday, rebounding after Thursday’s earnings report sent the stock lower. The company named CFO Salvatore Mancuso as incoming CEO, effective May 14, and is expanding exports to tap a federal excise-tax rebate. Altria’s Q4 net revenue fell 2.1% to $5.846 billion, with adjusted EPS at $1.30. Market share for its on! pouches dropped to 13% as competition from Philip Morris’s Zyn intensified.
30 January 2026
·
Charter Communications stock jumps as broadband losses come in lighter than feared

Charter Communications stock jumps as broadband losses come in lighter than feared

Charter Communications shares rose 8% to $206.76 after reporting a smaller-than-expected loss of 119,000 internet customers in Q4, beating analyst forecasts. Revenue fell 2% to $13.6 billion, missing estimates, while mobile line additions of 428,000 lagged expectations. Net income dropped to $1.3 billion. The company plans $11.4 billion in capital spending for 2026 amid ongoing competition and industry pressures.
30 January 2026
·
Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Joby Aviation shares fell 4.8% to $10.61 Friday after the company priced a $1.2 billion stock and convertible note offering at $11.35 per share, about 15% below the Jan. 28 close. The deal includes 52.86 million shares and $600 million in 0.75% convertible notes due 2032. Settlement is expected Monday, with underwriters holding options to increase both offerings. Rival eVTOL stocks also declined.
30 January 2026
·
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific shares rose 1.7% to $93.87 Friday afternoon, outpacing a broader market decline. The move comes ahead of the company’s Feb. 4 earnings report and conference call, its first since announcing a $14.5 billion deal to acquire Penumbra. Investors are watching for details on the acquisition’s impact and the 2026 outlook.
30 January 2026
···
1 … 320 321 322 323 324 … 1,402

Stock Market Today

  • Canadian National Railway (TSX:CNR) Near Fair Value After Recent Price Rise
    April 30, 2026, 12:19 AM EDT. Canadian National Railway's (TSX:CNR) share price has climbed 4.8% in the past month and 13.7% over the last year. The stock trades around CA$147.91, near its estimated intrinsic value of CA$150.02 from a discounted cash flow (DCF) analysis, suggesting it is fairly valued. Canadian National, a key North American freight infrastructure player, is supported by a robust capital investment program and stable cash flow projections through 2029 and beyond. Despite this, its 13.7% return trails some peers, reflecting ongoing market concerns about rail efficiency, regulation, and cross-border trade impacts. Investors should monitor updates as shifts in factors influencing long-term cash generation could affect valuation.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 30.04.2026

30 April 2026
OCBC will pay a total dividend of S$0.58 per share in May, including a S$0.16 special dividend. UOB declared a final dividend of S$0.71 per share despite lower net interest income. ST Engineering reported higher revenue and profit, with a S$0.23 per share dividend. Jardine Matheson raised its annual dividend 4% to US$2.35 per share, payable mid-May.
Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Go toTop